The effect of PKC activation and inhibition on osteogenic differentiation of human mesenchymal stem cells
- 23 December 2009
- journal article
- research article
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 4 (5) , 329-339
Abstract
Human mesenchymal stem cells (hMSCs) are being considered for several areas of clinical therapy, due to their multipotent nature. For instance, osteogenic hMSCs are applied in bone tissue engineering, but current differentiation protocols need further optimization before they can be clinically applied. Protein kinase C (PKC) family members have been implicated in bone metabolism, which prompted us to use a pharmaceutical approach to manipulate PKC signalling in hMSCs. Inhibition of PKC resulted in a dose-dependent inhibition of dexamethasone-induced osteogenic differentiation. Surprisingly, PKC activation using phorbol 12-myristate 13-acetate (PMA) also resulted in inhibition of osteogenesis, although we observed that inhibition was more pronounced at low than at high concentrations of PMA. Furthermore, we observed that inhibition of PKCδ blocked alkaline phosphatase (ALP, an early marker of osteogenic differentiation) expression, whereas inhibition of the conventional PKC subfamily and PKCµ using Gö6976 resulted in an induction of ALP activity, collagen (I) expression and mineralization. In conclusion, inhibition of the conventional PKCs/PKCµ and activation of PKCδ could further benefit osteogenic differentiation of hMSCs in vitro and in vivo, which is currently under investigation. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 53 references indexed in Scilit:
- cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivoProceedings of the National Academy of Sciences, 2008
- Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on boneBone, 2007
- Cell-Based Bone Tissue EngineeringPLOS Medicine, 2007
- Runx2 phosphorylation induced by fibroblast growth factor‐2/protein kinase C pathwaysProteomics, 2006
- Protein Kinase C-independent Activation of Protein Kinase D Is Involved in BMP-2-induced Activation of Stress Mitogen-activated Protein Kinases JNK and p38 and Osteoblastic Cell DifferentiationJournal of Biological Chemistry, 2004
- Protein Kinase C Is a Mediator of the Synthesis and Secretion of Osteoprotegerin in Osteoblast-like CellsBiochemical and Biophysical Research Communications, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Regulation of expression and activity of four PKC isozymes in confluent and mechanically stimulated UMR‐108 osteoblastic cellsJournal of Cellular Physiology, 2001
- Protein Kinase C-Dependent Upregulation of N-Cadherin Expression by Phorbol Ester in Human Calvaria OsteoblastsExperimental Cell Research, 2001
- Expression and phorbol ester–induced down-regulation of protein kinase C isozymes in osteoblastsJournal of Bone and Mineral Research, 1996